Clinical trial
A Multicenter Trial of Localized Radiation Therapy to Inhibit Restenosis (GAMMA…
NCT00232778 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00232778 |
|---|---|
| Title | A Multicenter Trial of Localized Radiation Therapy to Inhibit Restenosis (GAMMA V) |
| Official title | A Multicenter Trial of Localized Radiation Therapy to Inhibit Restenosis (GAMMA V) |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | GAMMA-Iridium-192 catheter |
| Enrollment | 579 |
| Start date | May 1, 2000 |
| Completion | Jun 1, 2006 |
| First posted | Oct 5, 2005 |
| Last update posted | Apr 24, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: